ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.
| Autor: | Currier, Judith S1 (AUTHOR) jscurrier@mednet.ucla.edu, Moser, Carlee2 (AUTHOR), Eron, Joseph J3 (AUTHOR), Chew, Kara W1 (AUTHOR), Smith, Davey M4 (AUTHOR), Javan, Arzhang Cyrus5 (AUTHOR), Wohl, David Alain3 (AUTHOR), Daar, Eric S6 (AUTHOR), Hughes, Michael D2 (AUTHOR), Team, for the ACTIV-2/A5401 Study (AUTHOR) |
|---|---|
| Zdroj: | Journal of Infectious Diseases. 2023 Supplement, Vol. 288, pS77-S82. 6p. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|